Dr. ZHANG Jin graduated from Sun Yat-sen University in Guangzhou in 1993 and later obtained a master's degree in internal medicine from Zhejiang University School of Medicine. In 1996, she served as a visiting scholar at Loma Linda University Health in the United States, and in 2019, she was a visiting scholar at Harvard University. With over 30 years of experience in medicine, Dr. Zhang specializes in clinical practice, research, and education related to hematologic malignancies. Her expertise includes precision treatment for malignant lymphomas and multiple myeloma, as well as the diagnosis and treatment of myelodysplastic syndromes and leukemia. She currently serves as the Director of the Hematology Teaching and Research Office at the Clinical Third Division of Zhejiang University School of Medicine. Dr. Zhang has led or participated in several national and provincial research projects and published multiple research papers in journals such as Blood and Chinese Medical Journal. She has also contributed to the development of key guidelines, including the Comprehensive Management Guidelines for Lymphoma in China, the Treatment Guidelines for Hodgkin Lymphoma in China, and the 2024 Integrated Lymphoma Guidelines.

Vice Chairman of the Hematology Specialty Committee, China Primary Health Care Foundation

Member of the Lymphoma Professional Committee, China Anti-Cancer Association

Member of the Expert Committee on Multiple Myeloma, Chinese Society of Clinical Oncology

Member of the Integrated Rehabilitation Specialty Committee for Hematologic Tumors, China Anti-Cancer Association

Member of the MDS Academic Committee, Hematology Branch, Chinese Anti-Cancer Association